| a0f20cef-5d05-4008-b92c-c54586f7f2f2 | <span class="null">NULL</span> | 0093119 | METASTASE DE TUMOR PRIMARIO DESCONHECIDO (CARCINOMA EPIDERMO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 81a5eb6f-d04a-46f3-82cd-5123fcac7dc5 | ecdb9634-a5c8-45b2-ba7c-7194d02b3eb5 | 0093120 | MMONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTADIO II(ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 29dffb72-4944-447e-b600-5a35e59426d4 | d27a2eb7-ed35-4ef4-a14f-279f202c9249 | 0093121 | MOLDAGEM EM COLO E / OU CORPO UTERINO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7a52e421-96a5-47fb-8583-379d24cf441f | ecdb9634-a5c8-45b2-ba7c-7194d02b3eb5 | 0093122 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO I (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7f81f74c-2e17-425a-9e23-2e6eaaa0bbf4 | ecdb9634-a5c8-45b2-ba7c-7194d02b3eb5 | 0093123 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTADIO III (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7694793e-7147-4f08-aab2-536632bc22a3 | d27a2eb7-ed35-4ef4-a14f-279f202c9249 | 0093124 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| cfad7f0a-3b07-4e0b-93bc-e8117f9f8b4c | 42c14584-daee-47d8-974c-e167c3263f9f | 0093125 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO II | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 52eac7ee-2b4d-4d8e-b687-a1f02ebdaa53 | b06342b9-0413-4458-a21d-a7eb1fa5e945 | 0093126 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO III | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c247063b-779b-4af9-980e-e3f5bec3e0b3 | b06342b9-0413-4458-a21d-a7eb1fa5e945 | 0093127 | NARCOSE DE CRIANÇA (POR PROCEDIMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0e1c4619-2e68-4dc1-8837-13cc05402412 | df70dd45-6366-41bd-8028-d7f3a476bf04 | 0093128 | NARCOSE PARA BRAQUITERAPIA DE ALTA DOSE ( POR PROCEDIMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ae58ad72-be84-4c37-ab8c-071ffe223e6e | <span class="null">NULL</span> | 0093129 | NARCOSE PARA BRAQUITERAPIA DE ALTA DOSE (POR PROCEDIMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ef7a9eb4-89b6-4bf0-971d-b8f69817614b | 9368fdb1-1146-44d9-ac55-faaa21b921b4 | 0093130 | NEOPLASIA OVARIANA DE CELULAS GERMINATIVAS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e6925731-e617-4a47-8cc8-225b560b23b7 | 5093ddae-e405-444a-8aa8-9a5af6ff52bb | 0093131 | NEOPLASIA DE CELULAS GERMINATIVAS DE OVARIO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 447645d6-ce92-4a0f-8b4f-dbf77b2b7334 | 1af94c2e-1b96-41c1-a3be-12ad83275e0f | 0093132 | NEOPLASIA DE CELULAS GERMINATIVAS EXTRA-GONADAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0698e2c4-934d-4a07-844b-f19e4414d70f | 4d4ced5b-0036-4680-9dc0-305df74c56bb | 0093133 | NEOPLASIA DE CELULAS PLASMATICAS 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b0e8da3e-36f9-4b34-a156-f53b7dc66147 | 697bef2e-0773-45a6-ba82-8527120334ba | 0093134 | NEOPLASIA MALIGNA EPITELIAL DE CABECA E PESCOCO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 3cedd59d-234a-4fdf-8406-c519b146cb69 | 973a7e3c-aeb4-4e2d-af98-8fc55ccf55d0 | 0093135 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO III) - 2A | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 28c8f8a3-86e6-4c87-aa5c-e4c884be0aa3 | 29ded6ca-1b0e-4db0-9500-6667aa655ba3 | 0093136 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO III) - 1A L | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bf9665a1-f49f-47cd-8107-bf1739c72a61 | <span class="null">NULL</span> | 0093137 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIO IV OU RECIDIV | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| be47d231-5048-49e7-a4d3-027ef1c81e9b | ad85e0c9-2e6a-450d-9cf4-259b400951d3 | 0093138 | NEOPLASIA MALIGNA EPITELIAL DE OVARIO (ESTADIOS IA E IB/G3, | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b1baa859-162b-4eaf-a475-5c346d7f60ae | c865cea4-c4ee-494a-ba1f-1091be8f59fb | 0093139 | NEOPLASIA TROFOBLASTICA GESTACIONAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6226a1e2-a0e2-4fff-a922-5067346cae86 | b93e4c5a-89a4-40b3-a608-53d94994cee1 | 0093140 | NEOPLASIA TROFOBLASTICA GESTACIONAL (CORIOCARCINOMA DE RISCO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 51135801-109d-4072-ace0-d69490d0a400 | 265c2660-55fd-4a6a-88a9-13be6e56b9a6 | 0093141 | NEOPLASIA TROFOBLASTICA GESTACIONAL(CORIOCARCINOMA DE RISCO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0844aa00-5f62-4d8e-963c-85a24f994482 | 691c7610-3aea-4fde-b260-ab1d73c34af4 | 0093142 | OSTEOSSARCOMA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6bbc2975-3e02-4ade-a9ca-176121d3123d | <span class="null">NULL</span> | 0093143 | OSTEOSSARCOMA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| da33a151-8355-4be3-a9fa-26ee797c5e64 | <span class="null">NULL</span> | 0093144 | OSTEOSSARCOMA RECIDIVADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2a8cc1b5-3436-4a23-a1c9-9a232b497495 | <span class="null">NULL</span> | 0093145 | PLANEJAMENTO COMPLEXO ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c5d4226b-95a7-41f6-963f-1e05047b7bb7 | <span class="null">NULL</span> | 0093146 | PLANEJAMENTO DE BRAQUITERAPIA DE ALTA TAXA DE DOSE ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 84cffbf1-3c34-420d-85b9-8d94cb4c6063 | 27f04c69-b437-4ef7-b888-6da058cfa58e | 0093147 | PLANEJAMENTO SIMPLES (POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fa3529dd-95be-4a11-bfb8-2004fa02ab83 | c78a7197-96c8-4e27-8aa1-c913f18a121b | 0093148 | PLANEJAMENTO TRIDIMENSIONAL ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 1132e7a6-427d-414b-a8bc-e3c24dfad163 | 2ab15622-636a-4c08-9b0b-f223e86d43a4 | 0093149 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO I (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 8e5666f7-363c-45d3-89e2-4e0ae749e011 | 65e21349-3d1e-49ae-8b6a-56554e1abcce | 0093150 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO II (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 726e9eec-f815-480e-ae7b-a85c7b44609d | 27f04c69-b437-4ef7-b888-6da058cfa58e | 0093151 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO III | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ada72694-ecea-4988-9464-db2c6f6e11c6 | c78a7197-96c8-4e27-8aa1-c913f18a121b | 0093152 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO III (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| dc558d0d-803e-49a2-8a5c-a09ffcbf5110 | 65e21349-3d1e-49ae-8b6a-56554e1abcce | 0093153 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6363e14d-630c-4866-9865-86669afc527c | f88d9432-84c2-4a6b-8577-8b4313e11d7b | 0093154 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO II | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a4a603dc-eedc-46b6-92fa-335d61b91eba | 084ad618-70d0-4c91-b2a1-2d01e7bfbb31 | 0093155 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁGIO III | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5a432918-601f-4d10-8d9b-9765e8ae763f | 368901d1-5c4e-4f53-ac36-9f798eaadf65 | 0093156 | QUIMIOTERAPIA DE CARCINOMA DO FIGADO OU DO TRATO BILIAR AVANCADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5c8170f8-a4a7-415f-9f5e-434ced10dacf | 7e3dfa08-9c1b-4b7c-bccd-f20043f24507 | 0093157 | QUIMIOTERAPIA DE CARCINOMA EPIDERMOIDE/ADENOCARCINOMA DE ESOFAGO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e3efb588-f3d9-4e01-9aba-edf65ba73ebd | 58a4156f-8001-4bc8-aedb-1c4cb986d8f7 | 0093158 | QUIMIOTERAPIA DE CARCINOMA UROTELIAL AVANCADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0150b274-9190-41de-87d6-09d6196ea5c8 | be482f23-4373-4771-855e-66e5708e536b | 0093159 | QUIMIOTERAPIA DE LEUCEMIA MIELOIDE CRONICA EM FASE CRONICA - MARCADOR POSITIVO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| d8abd5c0-59db-4113-989a-cac2742585cc | 33a33de2-d09d-4c3f-8d7d-5f7f3e4af214 | 0093160 | QUIMIOTERAPIA DE LINFOMA DIFUSO DE GRANDES CELULAS B 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9eae2de9-b591-46a4-b7f7-d2c104faca0f | 5c9280db-490d-4adc-be62-ec67a5efa2e0 | 0093161 | QUIMIOTERAPIA DE NEOPLASIA DE CELULAS PLASMATICAS - 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e118fd24-3346-4c98-8c84-799eede9b7a6 | e32e3391-9d32-42a4-a638-67f12ff0976a | 0093162 | QUIMIOTERAPIA DE NEOPLASIA MALIGNA DO TIMO AVANÇADA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 11895069-96f5-49cc-bd89-c075586780e9 | 5ded7081-d3f6-4268-ad8e-d11434924809 | 0093163 | QUIMIOTERAPIA DO ADENOCARCINOMA DE ESTOMAGO (POS OPERATORIA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6dbcc3a7-0fc4-4664-98d8-28a55b9c15af | 28e918aa-abec-499b-b0dd-8928171492d4 | 0093164 | QUIMIOTERAPIA DO ADENOCARCINOMA DE ESTOMAGO (PRE-OPERATORIA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 37c8658f-17ac-45f8-a0da-cef669c3b75e | 298bf386-0628-4208-b663-aa6d80975ec0 | 0093165 | QUIMIOTERAPIA DO ADENOCARCINOMA DE RETO (ESTADIOS II E III OU DUKES B E C) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 922e8a49-f437-4b68-9f70-7dcd39b7b476 | 315c8f8d-6f2d-418e-8db1-9c79998c14c9 | 0093166 | QUIMIOTERAPIA DO CARCINOMA DE MAMA (PRÉVIA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 489b1d17-5822-47cc-b2b7-a4b4157aa094 | 3666cdd4-0766-496a-9d06-c8c61bb8a6ba | 0093167 | QUIMIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c5bca999-0704-43d3-9e71-89422da87118 | 5891323f-bb3c-4765-935d-a0aa190e441c | 0093168 | QUIMIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO -1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |